Answers are grounded in this paper and cite their sources.
The benefit of cochlear implantation is undermined when electrode insertion triggers inflammation, peri-electrode fibrosis, and neural damage within the delicate cochlear microenvironment. Yet current coating strategies can hardly combine insertion-phase mechanical protection with sustained suppression of fibrotic activation. In this study, a hydrogel electrode coating was developed that enables temporally programmed, full-course protection throughout the cochlear implantation process, integrating lubricated self-healing protection during insertion with sustained anti-fibrotic and neuroprotective therapy after implantation. A soft GelMA-oxidized dextran (ODex) network repairs insertion-induced defects, while a zwitterionic hydrated surface reduces friction and suppresses cell adhesion. Coupled with sustained PFD release from PLGA reservoirs, the coating effectively mitigates inflammation and inhibits fibrosis through the FAK-RhoA/ROCK pathway, thereby preserving cochlear neural integrity. In rat and guinea pig implantation models, the coated electrodes effectively suppressed early intracochlear inflammation and subsequent fibrotic remodeling, ultimately translating into significant preservation of auditory function, as evidenced by improved auditory brainstem response thresholds. This hydrogel electrode technology not only enhances auditory outcomes for patients with hearing loss but also establishes a versatile platform for next generation cochlear implants.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: